Geneos Wealth Management’s Shore Bancshares SHBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.9K Hold
2,727
﹤0.01% 1422
2025
Q4
$48.2K Buy
+2,727
New +$45.7K ﹤0.01% 1406
2022
Q3
Sell
-1,150
Closed -$21K 2500
2022
Q2
$21K Hold
1,150
﹤0.01% 1668
2022
Q1
$23K Hold
1,150
﹤0.01% 1742
2021
Q4
$23K Hold
1,150
﹤0.01% 1823
2021
Q3
$20K Hold
1,150
﹤0.01% 1923
2021
Q2
$19K Hold
1,150
﹤0.01% 1945
2021
Q1
$19K Hold
1,150
﹤0.01% 2110
2020
Q4
$20K Hold
1,150
﹤0.01% 1919
2020
Q3
$11K Hold
1,150
﹤0.01% 1924
2020
Q2
$12K Hold
1,150
﹤0.01% 1851
2020
Q1
$11K Hold
1,150
﹤0.01% 1784
2019
Q4
$19K Hold
1,150
﹤0.01% 1712
2019
Q3
$17K Hold
1,150
﹤0.01% 1687
2019
Q2
$18K Hold
1,150
﹤0.01% 1689
2019
Q1
$17K Hold
1,150
﹤0.01% 1646
2018
Q4
$16K Hold
1,150
﹤0.01% 1607
2018
Q3
$20K Hold
1,150
﹤0.01% 1573
2018
Q2
$21K Hold
1,150
﹤0.01% 1430
2018
Q1
$21K Hold
1,150
﹤0.01% 1380
2017
Q4
$19K Hold
1,150
﹤0.01% 1413
2017
Q3
$19K Hold
1,150
﹤0.01% 1340
2017
Q2
$18K Buy
+1,150
New +$19.1K ﹤0.01% 1317

Other funds holding SHBI

Geneos Wealth Management's SHBI Position: Q1 2026 in Review

Geneos Wealth Management held its Shore Bancshares (SHBI) position steady in Q1 2026 at 2,727 shares worth $50.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Geneos Wealth Management first reported a position in SHBI in Q2 2017 and has held it in 23 quarters since. 163 funds tracked by Wall St. Rank hold SHBI as of Q1 2026.

  • Geneos Wealth Management held 2,727 shares of Shore Bancshares worth $50.9K as of Q1 2026.
  • Geneos Wealth Management left its Shore Bancshares share count unchanged in Q1 2026.
  • Shore Bancshares made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1422 holding.
  • Geneos Wealth Management first reported a position in Shore Bancshares in Q2 2017 and has held it in 23 quarters since.
  • 163 funds tracked by Wall St. Rank held Shore Bancshares as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.